Drugs and Public Health | Johns Hopkins | Bloomberg School of Public Health

Drugs Headlines

Explore the latest public health research and insights about drugs.

a vial of insulin with three syringes resting next to it

Why Eli Lilly’s Insulin Price Cap Announcement Matters

March 13, 2023

Insulin manufacturer Eli Lilly follows the government’s lead with a $35 price cap. Will manufacturers follow suit?

Documenting Pharma’s Role in the Opioid Crisis

October 04, 2022

Opioid industry documents illuminate the cynical strategies that led to thousands of deaths. Can an archive turn the tragic past into a better future?

Two senior citizens sit at a table reviewing a Medicare form.

What the Inflation Reduction Act Means for Medicare and Drug Pricing

September 21, 2022

For nearly 20 years, the Medicare program has been at the mercy of the private sector. But the Inflation Reduction Act has the potential to save Americans billions of dollars in drug costs.

Graphic of two vials of COVID-19 vaccines

What You Need to Know About Bivalent Boosters for COVID-19

August 31, 2022

An updated COVID-19 vaccine recipe offers new hope for curbing the pandemic.

Journal Special Issue Offers Evidence and Guidance Supporting National PrEP Program to Turn Tide on HIV

July 29, 2022

Special issue includes research and commentary addressing important considerations for national PrEP program that would lower prices and expand access.

New Documents Show McKinsey’s Role in Opioid Epidemic

June 30, 2022

The UCSF-JHU Opioid Industry Documents Archive released more than 114,000 documents related to McKinsey & Company's work showing how they advised opioid makers to help increase sales, despite the growing public outcry over the opioid epidemic.

Drugs Faculty

Looking for prominent public health experts in the field of drugs? They’re here at the Bloomberg School of Public Health.

Joshua M. Sharfstein

Professor of the Practice

Health Policy and Management

Joshua Sharfstein, MD, works to develop and promote public health strategies, healthcare payment approaches, and regulatory policies that advance health and equity.

Caleb Alexander

Professor

Epidemiology

G. Caleb Alexander, MD, MS, is a practicing internist and epidemiologist focused on maximizing the use, safety, and effectiveness of prescription medicines.

Gerard Anderson

Professor

Health Policy and Management

Gerard Anderson, PhD, works with policymakers to control health care spending.

Aditi P. Sen

Assistant Professor

- Adjunct

Aditi Sen, PhD, MA, is a health economist working to design and implement payment and delivery systems that improve quality of and access to care for all Americans.

Drugs